Demographic and clinical characteristics of patients with diabetes presenting to an urban public hospital ophthalmology clinic

Ophthalmology

Volumn 105, Issue 8, 1998, Pages 1373-1379

  Baker, Richard S ^a,b   Watkins, Neil L ^a   Wilson, M Roy ^a,b   Bazargan, Mohsen ^a   Flowers Jr , Charles W ^a,b  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CATARACT; CLINICAL FEATURE; DEMOGRAPHY; DIABETES MELLITUS; DIABETIC RETINOPATHY; EYE DISEASE; FEMALE; GLAUCOMA; HUMAN; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PUBLIC HOSPITAL; RETINA MACULA EDEMA; URBAN AREA; VISUAL IMPAIRMENT;

EID: 0031767423     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(98)98015-0     Document Type: Article

References (23)

1. National Society to Prevent Blindness. Operational Research Dept. Vision problems in the U.S.: a statistical analysis: National Society to Prevent Blindness. New York: The Society, 1980;1-46.
2. Herman WH, Teutsch SM, Sepe SJ, et al. An approach to the prevention of blindness in diabetes. Diabetes Care 1983;6: 608-13.
3. Klein R, Klein BEK. Vision disorders in diabetes. In: National Diabetes Data Group. Diabetes in America: Diabetes data compiled 1984. Bethesda, MD: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases, 1985; chapter 13 (DHHS publication; no. CNIH) 85-1468.
4. The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS report number 8. Ophthalmology 1981;88: 583-600.
5. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985;103:1796-806.
6. Ferris FL III. How effective are treatments for diabetic retinopathy? JAMA 1993;269:1290-1.
7. Javitt JC, Canner JK, Sommer A. Cost effectiveness of current approaches to the control of retinopathy in type I diabetics. Ophthalmology 1989;96:255-64.
8. Dasbach EJ, Fryback DG, Newcomb PA, et al. Cost-effectiveness of strategies for detecting diabetic retinopathy. Med Care 1991;29:20-39.
9. Kahn HA, Hiller R. Blindness caused by diabetic retinopathy. Am J Ophthalmol 1974;78:58-67.
10. Haffner SM, Fong D, Stern MP, et al. Diabetic retinopathy in Mexican Americans and non-Hispanic whites. Diabetes 1988; 37:878-84.
11. Klein R. Retinopathy and other ocular complications in diabetes. In: Olefsky JM, Sherwin RS, eds. Diabetes Mellitus: Management and Complications. New York: Churchill Livingstone, 1985;101:58 (Contemporary issues in endocrinology and metabolism, v. 1).
12. Klein R. Retinopathy and other ocular complications in diabetes. In: Olefsky JM, Sherwin RS, eds. Diabetes Mellitus: Management and Complications. New York: Churchill Livingstone, 1985;101:58 (Contemporary issues in endocrinology and metabolism, v. 1).
13. Witkin SR, Klein R. Ophthalmologic care for persons with diabetes. JAMA 1984;251:2534-7.
14. Sprafka JM, Fritsche TL, Baker RS, et al. Prevalence of undiagnosed eye disease in high-risk diabetic individuals. Arch Intern Med 1990;150:857-61.
15. American College of Physicians, American Diabetes Association, and American Academy of Ophthalmology. Screening guidelines for diabetic retinopathy. Clinical guideline. Ann Intern Med 1992;116:683-5.
16. Siegel B. Re-engineering the public hospital system: saving the safety net. Bull N Y Acad Med 1996;73:357-69.
17. Rask KJ, Williams MV, Parker RM, McNagny SE. Obstacles predicting lack of a regular provider and delays in seeking care for patients at an urban public hospital. JAMA 1994;271: 1931-3.
18. Burns R, Nichols LO, Graney MJ, Applegate WB. Mortality in a public and a private hospital compared: the severity of antecedent disorders in Medicare patients. Am J Public Health 1993;83:966-71.
19. Brechner RJ, Cowie CC, Howie LJ, et al. Ophthalmic examination among adults with diagnosed diabetes mellitus. JAMA 1993;270:1714-8.
20. Tielsch JM, Sommer A, Katz J. Socioeconomic status and visual impairment among urban Americans. Arch Ophthalmol 1991;109:637-41.
21. Seddon JM. The differential burden of blindness in the United States. N Engl J Med 1991;325:1440-2.
22. Ferraro KF, Farmer MM. Double jeopardy, aging as leveler, or persistent health inequality? A longitudinal analysis of white and black Americans. J Gerontol B Psychol Sci Soc Sci 1996;51:8319-28.
23. Moss SE, Klein R, Klein BEK. Factors associated with having eye examinations in persons with diabetes. Arch Fam Med 1995;4:529-34.